AstraZeneca Shares Gain 2% on CDSCO Approval
Shares of AstraZeneca Pharma Ltd were trading 2% higher on Friday, 30 May, on securing approval from the Central Drugs Standard Control Organisation (CDSCO). The company, in its regulatory filing, announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India, to import and…
